PAN was never a competitor to IDT. They operate in quite differnt markets. Also, it is my recollection that the AstraZeneca work was abandoned about twelve months ago when ZD 9331 proved to be a dud.
IDT has been a very fast grower over than past ten years or so but its growth rate has slowed to around 10% pa over the last couple of years and this has impacted the share price. Goos long term buy though, IMHO, and I hold a few.
any followers? pays a dividend too
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.015(4.84%) |
Mkt cap ! $77.95M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 32.0¢ | $32.61K | 99.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 36927 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 15.24pm 14/05/2021 (20 minute delay) ? |
 (live)
|
|||||
|
Last
32.0¢ |
Change
0.015 ( 3.23 %) |
||||
| Open | High | Low | Volume | ||
| 32.5¢ | 33.5¢ | 32.0¢ | 33205 | ||
| Last updated 15.42pm 14/05/2021 (live) ? | |||||
| IDT (ASX) Chart |